Wiley Interdisciplinary Reviews-nanomedicine And Nanobiotechnology
- 期刊全稱:Wiley Interdisciplinary Reviews-nanomedicine And Nanobiotechnology
- 簡稱:WIRES NANOMED NANOBI
- ISSN:1939-5116
- ESSN:1939-5116
- 研究方向:NANOSCIENCE & NANOTECHNOLOGY - MEDICINE, RESEARCH & EXPERIMENTAL
投稿咨詢
免費咨詢
2023最新分區
Wiley Interdisciplinary Reviews-nanomedicine And Nanobiotechnology英文簡介
Nanotechnology is universally recognized as one of the most important scientific fields of the twenty-first century. Biomedical applications of this technology include nanobiotechnology and nanomedicine, one of seven emerging research areas highlighted by, and funded through, the NIH Roadmap for Medical Research. The advancement of this field relies on the combined efforts of researchers from many different backgrounds, including clinicians, biomedical engineers, materials scientists, applied physicists, and toxicologists. The need for a high-quality interdisciplinary review forum was pressing, and WIREs Nanomedicine and Nanobiotechnology looks to fill that niche. The topical coverage includes: Toxicology and regulatory issues; Implantable materials and surgical technologies; Diagnostic tools; Nanotechnology approaches to biology; Therapeutic approaches and drug discovery; Biology-inspired nanomaterials.
Wiley Interdisciplinary Reviews-nanomedicine And Nanobiotechnology中文簡介
《Wiley Interdisciplinary Reviews-nanomedicine And Nanobiotechnology》是一本由WILEY出版商出版的專業醫學期刊,該刊創刊于2008年,刊期Bimonthly,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:醫學 2區,小類學科:醫學:研究與實驗 2區;納米科技 3區;在JCR(Journal Citation Reports)分區等級為Q1。該刊發文范圍涵蓋醫學:研究與實驗等領域,旨在及時、準確、全面地報道國內外醫學:研究與實驗工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為9.423,平均審稿速度約稿?周期不定。
中科院分區最新升級版(當前數據版本:2021年12月最新升級版)
大類學科 |
分區 |
小類學科 |
分區 |
Top期刊 |
綜述期刊 |
醫學 |
2區 |
MEDICINE, RESEARCH & EXPERIMENTAL
醫學:研究與實驗
NANOSCIENCE & NANOTECHNOLOGY
納米科技
|
2區
3區
|
否 |
是 |
JCR分區(當前數據版本:2021-2022年最新版)
JCR分區等級 |
JCR所屬學科 |
分區 |
影響因子 |
Q1 |
MEDICINE, RESEARCH & EXPERIMENTAL |
Q1 |
9.423 |
NANOSCIENCE & NANOTECHNOLOGY |
Q2 |
期刊指數
影響因子 |
h-index |
Gold OA文章占比 |
研究類文章占比 |
OA開放訪問 |
平均審稿速度 |
9.423 |
-- |
11.22% |
0.00% |
未開放 |
約稿?周期不定 |
IF值(影響因子)趨勢圖